Intranasal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances Protection by Parenteral Mycobacterium bovis BCG Immunization against Pulmonary Tuberculosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Infection and Immunity

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/IAI.00517-06PMID 16861651PMCID PMC1539608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune Responses Induced in Cattle by Vaccination with a Recombinant Adenovirus Expressing Mycobacterial Antigen 85A and Mycobacterium bovis BCG

  2006cited by this paper
• Memory T Cell Populations in the Lung Airways Are Maintained by Continual Recruitment1

  2006cited by this paper
• Adenoviral Vectors for Mucosal Vaccination Against Infectious Diseases

  2005cited by this paper
• Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

  2005cited by this paper
• Immune responses to tuberculosis in developing countries: implications for new vaccines

  2005cited by this paper
• Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

  2005cited by this paper
• TB vaccines for the World.

  2005cited by this paper
• TB vaccines for the World.

  2005cited by this paper
• Focus on tuberculosis research

  2005cited by this paper
• Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen1

  2005influential reference
• Cellular immune responses induced in cattle by heterologous prime–boost vaccination using recombinant viruses and bacille Calmette–Guérin

  2004cited by this paper
• Anatomical features of anti-viral immunity in the respiratory tract

  2004cited by this paper
• Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

  2004cited by this paper
• Activation of CD8 T Cells by Mycobacterial Vaccination Protects against Pulmonary Tuberculosis in the Absence of CD4 T Cells1

  2004cited by this paper
• Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis1

  2004influential reference
• Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara1

  2003cited by this paper
• Recombinant Modified Vaccinia Virus Ankara Administration and Boosting with a Bacille Calmette-Guérin Vaccine Using Mucosal of Mycobacterium tuberculosis Efficacy Against Enhanced Immunogenicity and Protective

  2003cited by this paper
• A DNA Prime-Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis

  2003cited by this paper
• Revaccination of Neonatal Calves with Mycobacterium bovis BCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination

  2003cited by this paper
• Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

  2003cited by this paper
• Tuberculosis vaccines: the past, present and future

  2002cited by this paper
• Oral Vaccination with Subunit Vaccines Protects Animals against Aerosol Infection with Mycobacterium tuberculosis

  2002cited by this paper
• Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer.

  2002cited by this paper
• Antigen-Specific CD8+ T Cells Persist in the Upper Respiratory Tract Following Influenza Virus Infection1

  2001cited by this paper
• Priming by DNA Immunization Augments Protective Efficacy of Mycobacterium bovis Bacille Calmette-Guerin against Tuberculosis

  2001cited by this paper
• Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.

  2000cited by this paper
• Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi

  1996cited by this paper
• Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.

  1996cited by this paper

• Intranasal Vaccination with a Recombinant Adeno-Associated Virus Type 6 Encoding SapM Confers Protection Against Tuberculosis

  2026cites this paper
• BCG Vaccine-Induced Innate and Adaptive Pulmonary Immunity Correlating with Protective Efficacy Against Mycobacterium tuberculosis in the Lungs

  2025cites this paper
• Evaluation of a strategy to enhance the efficacy and ease of application of porcine reproductive and respiratory syndrome virus vaccines.

  2025cites this paper
• A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models

  2025cites this paper
• The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against Mycobacterium tuberculosis

  2024cites this paper
• Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.

  2024cites this paper
• Routing Innate and Adaptive Immune response against M. tuberculosis and boosting Mycobacterium bovis Bacillus Calmette Güerin (BCG) vaccine immunity through prime boost protocols

  2023cites this paper
• Novel and Innovative Approach of Nanotechnology with their Applications in the Management of Infectious Disease, Tuberculosis: An Overview.

  2022cites this paper
• A century of attempts to develop an effective tuberculosis vaccine: Why they failed?

  2022cites this paper
• Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

  2022cites this paper
• Genetics and Molecular Biology

  2022cites this paper
• Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung

  2022cites this paper
• A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19

  2022cites this paper
• Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development

  2022cites this paper
• Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults

  2021cites this paper
• PigsSystemic Antibody Immune Responses in Induces Powerful Protective Local T Cell and Immunization with Influenza Vaccine Simultaneous Aerosol and Intramuscular

  2021cites this paper
• A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice

  2021cites this paper
• A review of the BCG vaccine and other approaches toward tuberculosis eradication

  2021cites this paper
• An Update on Tuberculosis Vaccines.

  2021cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs

  2020cites this paper
• Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma

  2020cites this paper
• Recombinant Adenovirus Vectors as Mucosal Vaccines

  2020cites this paper
• Tuberculosis vaccine development: from classic to clinical candidates

  2020cites this paper
• Mycobacterium tuberculosis–Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell–Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways

  2019cites this paper
• Tuberculosis vaccine candidates based on mycobacterial cell envelope components.

  2019cites this paper
• BCG-induced T cells shape Mycobacterium tuberculosis infection before reducing the bacterial burden

  2019cites this paper
• Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial

  2019cites this paper
• Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.

  2019influential citation
• Cutting Edge: Bacillus Calmette–Guérin–Induced T Cells Shape Mycobacterium tuberculosis Infection before Reducing the Bacterial Burden

  2019cites this paper
• Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges

  2019cites this paper
• Novel vaccine candidates against Mycobacterium tuberculosis.

  2018cites this paper
• Next-Generation Vaccines Based on Bacille Calmette–Guérin

  2018cites this paper
• Temporal Requirement for Pulmonary Resident and Circulating T Cells during Virulent Francisella tularensis Infection

  2018cites this paper
• Novel Vaccine Candidates against Tuberculosis.

  2018cites this paper
• Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model

  2018cites this paper
• Loss of Cellular Immune Response against Shared Mycobacterial Antigens is Associated with Active Pulmonary Tuberculosis in Adults

  2018cites this paper
• Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization

  2018cites this paper
• Tuberculosis Prevention and Treatment: Achievements and Challenges in the Vaccine Development Process

  2018cites this paper
• Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice

  2017cites this paper
• Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.

  2017cites this paper
• Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract

  2017cites this paper
• Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge

  2017cites this paper
• A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system

  2017cites this paper
• Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine

  2017cites this paper
• Investigating the role of the pulmonary innate immune system in anti-tuberculosis immunity

  2017cites this paper
• Maintenance of Latent Infection, with Correlates of Protective Immunity

  2017cites this paper
• The role of lung tissue-resident memory T cells in protection against tuberculosis

  2017cites this paper
• A review of clinical models for the evaluation of human TB vaccines

  2016cites this paper
• Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy

  2016cites this paper
• Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus

  2016cites this paper
• Adenoviral Vector Vaccines Antigen Transgene

  2016cites this paper
• Immunotherapy for tuberculosis: future prospects

  2016cites this paper
• Current status of new tuberculosis vaccine in children

  2016cites this paper
• Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB.

  2016cites this paper
• Clinical Testing of Tuberculosis Vaccine Candidates

  2016cites this paper
• Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy.

  2016cites this paper
• Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens

  2016cites this paper
• A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis

  2016cites this paper
• Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis

  2015influential citation
• Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection

  2015influential citation
• Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.

  2015cites this paper
• Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

  2015cites this paper
• Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle

  2015cites this paper
• Tuberculosis vaccines--state of the art, and novel approaches to vaccine development.

  2015cites this paper
• Aerosol immunisation for TB: matching route of vaccination to route of infection

  2015cites this paper
• Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model

  2015cites this paper
• Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders

  2015cites this paper
• Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine

  2015influential citation
• Characterization of the Antigen-Specific CD4+ T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes

  2015cites this paper
• Role of B Cells in Mucosal Vaccine–Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis

  2015cites this paper
• The Tuberculosis Vaccines Pipeline : A New Path to the Same Destination ?

  2015cites this paper
• Mycobacterium tuberculosis Surface-binding Antibodies Influence Early Infection Events

  2015cites this paper
• Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial

  2014cites this paper
• Vaccine against tuberculosis: what’s new?

  2014cites this paper
• A Novel Murine Cytomegalovirus Vaccine Vector Protects against Mycobacterium tuberculosis

  2014influential citation
• tuberculosis Mycobacterium Protect against High-Dose Lungs of Rhesus Macaques but Fails To Robust Cellular Immune Responses in the Aerosol Vaccination with AERAS-402 Elicits

  2014cites this paper
• A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens

  2014cites this paper
• Tuberculosis Vaccines and Prevention of Infection

  2014cites this paper
• Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge

  2014cites this paper
• Impfung gegen Tuberkulose

  2014cites this paper
• The role of B cells in respiratory mucosal AdHu5Ag85A vaccine-induced immunity against tuberculosis

  2014influential citation
• Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG.

  2014cites this paper
• Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.

  2014cites this paper
• Lactobacilli as live vectors for oral vaccination against TB

  2014cites this paper
• The Role of T cells In Mucosal Immunity against Mycobacterium tuberculosis (Mtb) Infection: A Review of Current Understanding

  2014cites this paper
• Modulation of respiratory mucosal immunity against pulmonary tuberculosis

  2014cites this paper
• Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.

  2014cites this paper
• Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.

  2014cites this paper
• Harnessing local and systemic immunity for vaccines against tuberculosis

  2013cites this paper
• Recent developments in tuberculosis vaccines

  2013cites this paper
• Tuberculosis vaccines: time to think about the next generation.

  2013cites this paper
• Vaccination against tuberculosis: how can we better BCG?

  2013cites this paper
• 2013 pipeline report: HIV hepatitis C virus (HCV) and tuberculosis (TB) drugs diagnostics vaccines preventive technologies research toward a cure and immune-based and gene therapies in development.

  2013cites this paper
• Molecular Factors that Influence BCG Vaccine Properties

  2013cites this paper
• TB Vaccines: State of the Art and Progresses

  2013cites this paper
• A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression

  2013cites this paper
• Inhaled Vaccines for the Prevention of Tuberculosis

  2013cites this paper
• Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells

  2013influential citation
• Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.

  2013cites this paper